HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teresa Klinowska Selected Research

Phosphoric Monoester Hydrolases (Phosphatases)

9/2014Overcoming endocrine resistance due to reduced PTEN levels in estrogen receptor-positive breast cancer by co-targeting mammalian target of rapamycin, protein kinase B, or mitogen-activated protein kinase kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teresa Klinowska Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 11/2007
14Breast Neoplasms (Breast Cancer)
01/2022 - 02/2009
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 02/2010
2Circulating Neoplastic Cells
01/2022 - 12/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Kidney Neoplasms (Kidney Cancer)
11/2018
1Lung Neoplasms (Lung Cancer)
09/2014
1Inflammatory Breast Neoplasms
05/2014
1Carcinogenesis
04/2012
1Squamous Cell Carcinoma of Head and Neck
02/2010
1Cystitis
02/2009
1Urinary Retention
02/2009

Drug/Important Bio-Agent (IBA)

7Estrogen ReceptorsIBA
01/2022 - 09/2014
7AZD 8931IBA
03/2016 - 02/2010
4Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2010
4AZD9496IBA
01/2022 - 01/2018
4Lapatinib (GW572016)FDA Link
02/2020 - 02/2010
4Phosphotransferases (Kinase)IBA
02/2020 - 02/2010
4Fulvestrant (Faslodex)FDA Link
01/2020 - 04/2014
3vistusertibIBA
01/2022 - 11/2015
3human ERBB2 proteinIBA
03/2016 - 08/2014
3ErbB Receptors (EGF Receptor)IBA
10/2014 - 02/2010
2Circulating Tumor DNAIBA
01/2022 - 12/2018
2AZD8186IBA
01/2022 - 11/2018
2Proteins (Proteins, Gene)FDA Link
02/2020 - 08/2014
2LigandsIBA
12/2018 - 04/2014
2TOR Serine-Threonine KinasesIBA
08/2015 - 09/2014
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
08/2015 - 09/2014
2Pharmaceutical PreparationsIBA
09/2014 - 02/2009
1Prostate-Specific Antigen (Semenogelase)IBA
01/2022
1Abiraterone AcetateIBA
01/2022
1AntigensIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1IndazolesIBA
12/2020
1IronIBA
02/2020
1Protein Isoforms (Isoforms)IBA
11/2018
1src-Family KinasesIBA
03/2016
1Aromatase InhibitorsIBA
11/2015
1Mechanistic Target of Rapamycin Complex 1IBA
11/2015
1Mechanistic Target of Rapamycin Complex 2IBA
11/2015
1MTOR InhibitorsIBA
11/2015
1capivasertibIBA
08/2015
1TensinsIBA
09/2014
1Phenobarbital (Luminal)FDA Link
09/2014
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2014
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
09/2014
1Tyrosine Kinase InhibitorsIBA
09/2014
1osimertinibIBA
09/2014
1Trastuzumab (Herceptin)FDA Link
08/2014
1Paclitaxel (Taxol)FDA LinkGeneric
05/2014
1TamoxifenFDA LinkGeneric
04/2014
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
04/2012
1AZD4547IBA
04/2012
1Gefitinib (Iressa)FDA Link
02/2010
1Estradiol (Delestrogen)FDA LinkGeneric
02/2009
1Estrogens (Estrogen)FDA Link
02/2009
11-aminobenzotriazoleIBA
11/2007
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2007

Therapy/Procedure

10Therapeutics
01/2022 - 05/2014
1Precision Medicine
01/2022
1Oral Administration
04/2012